Literature DB >> 29126238

Seizure Outcome After Surgical Resection of Insular Glioma.

Doris D Wang1, Hansen Deng1, Shawn L Hervey-Jumper1, Annette A Molinaro1, Edward F Chang1, Mitchel S Berger1.   

Abstract

BACKGROUND: A majority of patients with insular tumors present with seizures. Although a number of studies have shown that greater extent of resection improves overall patient survival, few studies have documented postoperative seizure control after insular tumor resection.
OBJECTIVE: To (1) characterize seizure control rates in patients undergoing insular tumor resection, (2) identify predictors of seizure control, and (3) evaluate the association between seizure recurrence and tumor progression.
METHODS: The study population included adults who had undergone resection of insular gliomas between 1997 and 2015 at our institution. Preoperative seizure characteristics, tumor characteristics, surgical factors, and postoperative seizure outcomes were reviewed.
RESULTS: One-hundred nine patients with sufficient clinical data were included in the study. At 1 yr after surgery, 74 patients (68%) were seizure free. At final follow-up, 42 patients (39%) were seizure free. Median time to seizure recurrence was 46 mo (95% confidence interval 31-65 mo). Multivariate Cox regression analysis revealed that greater extent of resection (hazard ratio = 0.2899 [0.1129, 0.7973], P = .0127) was a significant predictor of seizure freedom. Of patients who had seizure recurrence and tumor progression, seizure usually recurred within 3 mo prior to tumor progression. Repeat resection offered additional seizure control, as 8 of the 22 patients with recurrent seizures became seizure free after reoperation.
CONCLUSION: Maximizing the extent of resection in insular gliomas portends greater seizure freedom after surgery. Seizure recurrence is associated with tumor progression, and repeat operation can provide additional seizure control.

Entities:  

Mesh:

Year:  2018        PMID: 29126238      PMCID: PMC6454798          DOI: 10.1093/neuros/nyx486

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  33 in total

1.  The insular lobe: physiopathological and surgical considerations.

Authors:  H Duffau; L Capelle; M Lopes; T Faillot; J P Sichez; D Fohanno
Journal:  Neurosurgery       Date:  2000-10       Impact factor: 4.654

Review 2.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 3.  Insular lesionectomy for refractory epilepsy: management and outcome.

Authors:  M von Lehe; J Wellmer; H Urbach; J Schramm; C E Elger; H Clusmann
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

4.  Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.

Authors:  Nader Sanai; Mei-Yin Polley; Mitchel S Berger
Journal:  J Neurosurg       Date:  2010-01       Impact factor: 5.115

5.  Surgical assessment of the insula. Part 1: surgical anatomy and morphometric analysis of the transsylvian and transcortical approaches to the insula.

Authors:  Arnau Benet; Shawn L Hervey-Jumper; Jose Juan González Sánchez; Michael T Lawton; Mitchel S Berger
Journal:  J Neurosurg       Date:  2015-09-04       Impact factor: 5.115

6.  Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection.

Authors:  Shawn L Hervey-Jumper; Jing Li; Joseph A Osorio; Darryl Lau; Annette M Molinaro; Arnau Benet; Mitchel S Berger
Journal:  J Neurosurg       Date:  2015-09-04       Impact factor: 5.115

7.  Functional outcome after language mapping for glioma resection.

Authors:  Nader Sanai; Zaman Mirzadeh; Mitchel S Berger
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

8.  Role of surgical resection in low- and high-grade gliomas.

Authors:  Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.598

9.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Authors:  Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

10.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

View more
  4 in total

Review 1.  Functional Mapping for Glioma Surgery, Part 2: Intraoperative Mapping Tools.

Authors:  Ramin A Morshed; Jacob S Young; Anthony T Lee; Shawn L Hervey-Jumper
Journal:  Neurosurg Clin N Am       Date:  2020-11-05       Impact factor: 2.509

2.  Challenging Giant Insular Gliomas With Brain Mapping: Evaluation of Neurosurgical, Neurological, Neuropsychological, and Quality of Life Results in a Large Mono-Institutional Series.

Authors:  Marco Rossi; Lorenzo Gay; Marco Conti Nibali; Tommaso Sciortino; Federico Ambrogi; Antonella Leonetti; Guglielmo Puglisi; Henrietta Howells; Paola Zito; Federico Villa; Gjulio Ciroi; Marco Riva; Lorenzo Bello
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

3.  Clinical and prognostic implications of rim restriction following glioma surgery.

Authors:  Assaf Berger; Garry Gali Tzarfati; Marga Serafimova; Pablo Valdes; Aaron Meller; Akiva Korn; Naomi Kahana Levy; Daniel Aviram; Zvi Ram; Rachel Grossman
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

4.  A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.

Authors:  Haitao Luo; Chuming Tao; Xiaoyan Long; Kai Huang; Xingen Zhu
Journal:  Aging (Albany NY)       Date:  2021-06-10       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.